Chunwei Xu, MD, PhD (Pathology and Biobank)

Pathology and Biobank Department, Affiliated Hospital of Academy of Military Medical Sciences, Beijing,China

He is an Attending physician and Scientific Research Secretary of the Pathology and Biobank Department, Affiliated Hospital of Academy of Military Medical Sciences, Beijing. He is a member of Chinese medical association (Pathology branch), and also a member of Journal of Clinical and Pathological Research and Chinese Journal of General Surgery. He is good at Molecular pathology genetic detection, the pathological diagnosis of the digestive system tumor, respiratory system tumor and breast tumor diagnosis. He has main translation the fourth edition of the WHO (2015) lung, pleura, thymus and cardiac tumor histologic contents (Dongmei Lin Review) and the WHO(2014) gynecological tumor histologic contents (Weicheng Xue Review). He has published 114 scientific papers in tumor field, Translation 49 English journal abstract. He participates in Colorectal serrated lesions morphological criteria and RAR alpha research the role of tumor cell proliferation regulation (the Capital Health Development Research Fund No.30872956), Colorectal serrated adenomas clinical pathological diagnosis standard and the relationship in the cancer research (the Capital Health Development Research Fund No.2007-3025), Abnormal DNA methylation and colorectal serrated lesions and cancerous correlation studies (the Capital Health Development Research Fund No.2011-5021-02), Recombinant human vascular endothelin suppression is the basis and clinical application research of malignant cavity effusion (Wu Jieping Medical Foundation of Clinical Scientific Research Fund No.320.6750.1360), ROS1 fusion gene in advanced non-small cell lung cancer clinical research targets advantage people (Affiliated Hospital of Academy of Military Medical Sciences Innovation Research Fund No.2014-10) and the tumor samples and quality of information platform to provide resources for translational medicine (Affiliated Hospital of Academy of Military Medical Sciences Innovation Research Fund No.2014-11).

Terms of Appointment: May 2015 - Aug 2017